News
Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...
Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...
Learn more about whether Ionis Pharmaceuticals, Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's ...
Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...
Learn more about whether Neurocrine Biosciences, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ ...
“The engines of the world’s AI infrastructure are being built in the United States for the first time,” Nvidia founder Jensen Huang said in a statement. “Adding American manufacturing helps us better ...
WTR is pleased to reveal the shortlist for the 2025 WTR Industry Awards. The WTR Industry Awards, which have been held ...
Job Title Sort ascending Business Location Site Date Posted Vodja skupine klinične proizvodnje (m/ž/d) / Senior Manager Clinical Manufacturing (m/f/d) Regulär, Full time Innovative Medicines Slovenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results